Health
Robert F. Kennedy Jr. reportedly urged task force to back multi-cancer screening tests
The Washington Sun reports that the health secretary privately advocated for multi-cancer blood test recommendations.
The short version
- Health Secretary Robert F. Kennedy Jr. privately told officials last winter that he wanted a federal advisory task force to recommend multi-cancer blood screening tests.[The Washington Sun]
- Kennedy recently appointed eight new members to reshape the Preventive Services Task Force, breaking with tradition by including medical specialists such as a radiologist.[The Washington Sun]
- An FDA advisory panel is scheduled to vote Wednesday on recommending approval for Grail's Galleri multi-cancer test.[The Washington Sun]
Key facts
- Health Secretary Robert F. Kennedy Jr. privately told attendees in a meeting last winter that he wanted the federal government to recommend multi-cancer blood tests.[The Washington Sun]
- Kennedy appointed eight new members to the Preventive Services Task Force, departing from standard practice by selecting specialists including a radiologist.[The Washington Sun]
- Grail's Galleri multi-cancer blood screening test faces an advisory panel vote on Wednesday regarding FDA approval.[The Washington Sun]
- Superpower sells Grail's Galleri test for $949, and Prenuvo sells whole-body MRI scans for approximately $2,500.[The Washington Sun]
- Prenuvo chief medical officer Dan Durand stated that his company is not seeking reimbursement for its MRI scans through its sponsorship of the MAHA Summit.[The Washington Sun]
What remains uncertain
- Whether the FDA advisory panel will vote to recommend approval for the Galleri test remains undecided ahead of Wednesday's meeting.[The Washington Sun]
- Kennedy has not publicly articulated how he intends the reshaped Preventive Services Task Force to operate going forward.[The Washington Sun]
Sources
Outlet counts describe coverage, not independent confirmation. Reports may share a wire service or original source.
- Kennedy Privately Backs Cancer-Detection Tests With Ties to MAHAThe Washington Sun